News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
David Planchard: A pleasure to discuss diagnostic and therapeutic advances in EGFR lung patients in Cannes
David Planchard/oncostream.com
Apr 4, 2025, 20:12

David Planchard: A pleasure to discuss diagnostic and therapeutic advances in EGFR lung patients in Cannes

David Planchard, Thoracic Oncologist, Professor at University Paris Saclay and Head of Thoracic Cancer Group at Gustave Roussy, shared a post on LinkedIn:

“A pleasure to have shared the podium in Cannes with Pr P.Hofman to discuss diagnostic and therapeutic advances in EGFR lung patients….important role of combination with chemotherapy (brain mets, high tumor burden, ctDNA, L858R…), TKIs and ADCs coming…”

David Planchard: A pleasure to discuss diagnostic and therapeutic advances in EGFR lung patients in Cannes

More posts featuring David Planchard.

cancer David Planchard EGFR lung patients Lung cancer OncoDaily Oncology
Special Coverage
Blog
Apr 4, 2025, 20:12
David Planchard: A pleasure to discuss diagnostic and therapeutic advances in EGFR lung patients in Cannes
Science
Apr 4, 2025, 19:52
Paolo Bossi: Immunotherapy plus cetuximab in advanced/metastatic cutaneous squamous cell carcinoma
Blog
Apr 4, 2025, 19:34
Matthew Kurian: The barriers to AI adoption in oncology
Blog
Apr 4, 2025, 19:19
Michaela Cada: Proud to be part of the SickKids family for 20 years
Blog
Apr 4, 2025, 19:05
Laurence Albiges: Day 1 of ESMO Preceptorship in metastatic urothelial RCC cancer
Blog
Apr 4, 2025, 18:55
The invisible killer in your lungs - Pink Hearts Cancer Support Foundation
Blog
Apr 4, 2025, 18:54
Yelak Biru: How pharma medical affairs and innovation teams can learn from Myelo’s AI journey
Insight
Apr 4, 2025, 18:36
Luis Lara-Mejía: Neoadjuvant aumolertinib converted 45.1% of unresectable stage III EGFRm NSCLC to resectable status
Insight
Apr 4, 2025, 18:06
Hypofractionated Radiotherapy for Soft Tissue Sarcomas
Blog
Apr 4, 2025, 17:45
Raj Batra: The absence of scientific rationale underlying contemporary clinical trials in lung cancers
Insight
Apr 4, 2025, 17:22
Sevinç Balli: Low dose Nivolumab maybe an option?
Blog
Apr 4, 2025, 15:12
Julia Ruthus: What does holistic survivorship care in metastatic breast cancer look like?